High Pet Ownership Rate Has Propelled the Growth of the Fetal Bovine Serum Market in the North America Region!

North America dominated the Fetal Bovine Serum market in 2021. The North America region is expected to lead the fetal bovine serum (FBS) market, driven by the strong demand for biopharmaceuticals and the well-established biotechnology industry in the region. Additionally, the North America region has a large number of established FBS manufacturers and distributors, which is expected to support the growth of the market. Recently, in January 2022, Thermo Fisher Scientific, a leading provider of life science solutions, announced the launch of a new FBS product called Invitrogen FBS Plus. This product is intended to provide a high-quality FBS solution for research applications, and it is expected to help Thermo Fisher Scientific expand its presence in the FBS market. Another recent development in the FBS market is the increasing use of alternative products, such as recombinant FBS, in the production of biopharmaceuticals. Recombinant FBS is produced using genetically engineered cells and is intended to be a safer and more ethical alternative to traditional FBS. This trend is expected to continue to gain momentum in the coming years, which may impact the growth of the traditional FBS market.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=43895

Further, the North America Fetal Bovine Serum Market is expected to grow at a strong CAGR of ~8% during the forecast period (2022-2030).

FIG. 1 North America Fetal Bovine Serum Market Revenue (2020-2030)- USD Mn

Based on application, the market is segmented into biopharmaceuticals, human & animal vaccines, and others. The biopharmaceuticals segment is expected to be the largest segment of the fetal bovine serum (FBS) market, driven by the increasing demand for biopharmaceuticals and the increasing use of FBS in their production. Biopharmaceuticals are complex proteins that are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, and genetic disorders. The production of biopharmaceuticals typically involves the use of animal-derived products, such as FBS, as they are critical for the growth and maintenance of cells used in cell culture.

Based on end-user, the market is segmented into biotechnology & pharmaceutical industries, academic institutes, and others. The biotechnology and pharmaceutical industries are expected to continue to be the largest segments of the FBS market in the coming years, due to the ongoing demand for biopharmaceuticals and the increasing use of FBS in the production of these products. Additionally, the biotechnology and pharmaceutical industries are expected to continue to invest in research and development, which is likely to drive demand for FBS.

For a detailed analysis of the Global Fetal Bovine Serum Market browse through – https://univdatos.com/report/fetal-bovine-serum-market/

Global Fetal Bovine Serum Market Segmentation

Market Insight, by Application

• Biopharmaceuticals
• Human & Animal Vaccines
• Others

Market Insights, by End-User

• Biotechnology & Pharmaceutical Industries
• Academic Institutes
• Others

Market Insight, by Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • India
  • Rest of APAC
• Rest of the World

Top Company Profiles

• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher (Cytiva)
• Merck KGaA (Sigma Aldrich)
• HiMedia Laboratories
• Bio-Techne
• PAN-Biotech
• Atlas Biologicals, Inc.
• GE Healthcare
• Sera Scandia (Biowest)